• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含天冬氨酸的线性肽对草酸钙结晶的调节作用

Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides.

作者信息

Wang Lijun, Qiu S Roger, Zachowicz William, Guan Xiangying, Deyoreo James J, Nancollas George H, Hoyer John R

机构信息

Department of Chemistry, Natural Sciences Complex, State University of New York at Buffalo, Buffalo, New York 14260, USA.

出版信息

Langmuir. 2006 Aug 15;22(17):7279-85. doi: 10.1021/la060897z.

DOI:10.1021/la060897z
PMID:16893227
Abstract

Calcium oxalate monohydrate (COM) kidney stone formation is prevented in most humans by urinary crystallization inhibitors. Urinary osteopontin (OPN) is a prototype of the aspartic acid-rich proteins (AARP) that modulate biomineralization. Synthetic poly(aspartic acids) that resemble functional domains of AARPs provide surrogate molecules for exploring the role of AARPs in biomineralization. Effects of linear aspartic acid-rich peptides on COM growth kinetics and morphology were evaluated by the combination of constant composition (CC) analysis and atomic force microscopy (AFM). A spacer amino acid (either glycine or serine) was incorporated during synthesis after each group of 3 aspartic acids (DDD) in the 27-mer peptide sequences. Kinetic CC studies revealed that the DDD peptide with serine spacers (DDDS) was more than 30 times more effective in inhibiting COM crystal growth than the DDD peptide with glycine spacers (DDDG). AFM revealed changes in morphology on (010) and (-101) COM faces that were generally similar to those previously described for OPN and citrate, respectively. At comparable peptide levels, the effects of step pinning and reduced growth rate caused by DDDS were remarkably greater. In CC nucleation studies, DDDS caused a greater prolongation of induction periods than DDDG. Thus, nucleation studies link changes in interfacial energy caused by peptide adsorption to COM to the CC growth and AFM results. These studies indicate that, in addition to the number of acidic residues, the contributions of other amino acids to the conformation of DDD peptides are also important determinants of the inhibition of COM nucleation and growth.

摘要

大多数人可通过尿液中的结晶抑制剂来预防一水合草酸钙(COM)肾结石的形成。尿液骨桥蛋白(OPN)是调节生物矿化的富含天冬氨酸蛋白(AARP)的一个原型。类似于AARP功能域的合成聚天冬氨酸提供了替代分子,用于探索AARP在生物矿化中的作用。通过恒定组成(CC)分析和原子力显微镜(AFM)相结合的方法,评估了线性富含天冬氨酸肽对COM生长动力学和形态的影响。在27聚体肽序列中,每3个天冬氨酸(DDD)基团后合成时引入一个间隔氨基酸(甘氨酸或丝氨酸)。动力学CC研究表明,带有丝氨酸间隔基团的DDD肽(DDDS)抑制COM晶体生长的效果比带有甘氨酸间隔基团的DDD肽(DDDG)高30倍以上。AFM显示,(010)和(-101)COM晶面上的形态变化通常分别与先前描述的OPN和柠檬酸盐的形态变化相似。在可比的肽水平下,DDDS引起的台阶钉扎效应和生长速率降低更为显著。在CC成核研究中,DDDS比DDDG导致诱导期延长更多。因此,成核研究将肽吸附到COM上引起的界面能变化与CC生长和AFM结果联系起来。这些研究表明,除了酸性残基的数量外,其他氨基酸对DDD肽构象的贡献也是抑制COM成核和生长的重要决定因素。

相似文献

1
Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides.富含天冬氨酸的线性肽对草酸钙结晶的调节作用
Langmuir. 2006 Aug 15;22(17):7279-85. doi: 10.1021/la060897z.
2
Molecular modulation of calcium oxalate crystallization.草酸钙结晶的分子调控
Am J Physiol Renal Physiol. 2006 Dec;291(6):F1123-31. doi: 10.1152/ajprenal.00136.2006.
3
Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide.通过骨桥蛋白磷酸肽的面特异性吸附控制草酸钙晶体生长。
J Am Chem Soc. 2007 Dec 5;129(48):14946-51. doi: 10.1021/ja0745613. Epub 2007 Nov 10.
4
Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals.骨桥蛋白肽的磷酸化介导其吸附到草酸钙晶体上并掺入其中。
Cells Tissues Organs. 2009;189(1-4):51-5. doi: 10.1159/000151724. Epub 2008 Aug 26.
5
On the catalysis of calcium oxalate dihydrate formation by osteopontin peptides.在骨桥蛋白肽促进草酸钙二水合物形成中的催化作用。
Colloids Surf B Biointerfaces. 2012 Aug 1;96:22-8. doi: 10.1016/j.colsurfb.2012.03.015. Epub 2012 Mar 29.
6
Surface aggregation of urinary proteins and aspartic Acid-rich peptides on the faces of calcium oxalate monohydrate investigated by in situ force microscopy.通过原位力显微镜研究一水草酸钙表面上尿蛋白和富含天冬氨酸肽的表面聚集情况。
Calcif Tissue Int. 2009 Jun;84(6):462-73. doi: 10.1007/s00223-009-9223-0. Epub 2009 Mar 18.
7
Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy.骨桥蛋白亚型存在下草酸钙晶体生长的动力学:扫描共聚焦干涉显微镜分析
Calcif Tissue Int. 2009 Mar;84(3):240-8. doi: 10.1007/s00223-008-9215-5. Epub 2009 Feb 3.
8
Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion-crystal interactions.草酸钙的结晶受分子亲水性和特定的聚阴离子-晶体相互作用控制。
Langmuir. 2009 Oct 6;25(19):11635-46. doi: 10.1021/la901145d.
9
Probing crystallization of calcium oxalate monohydrate and the role of macromolecule additives with in situ atomic force microscopy.利用原位原子力显微镜探究一水合草酸钙的结晶过程及大分子添加剂的作用
Langmuir. 2004 Sep 28;20(20):8587-96. doi: 10.1021/la0488755.
10
Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps.柠檬酸盐通过选择性结合原子台阶对一水合草酸钙结晶的调控
J Am Chem Soc. 2005 Jun 29;127(25):9036-44. doi: 10.1021/ja043591s.

引用本文的文献

1
Tartronic Acid as a Potential Inhibitor of Pathological Calcium Oxalate Crystallization.塔托酸作为病理性草酸钙结晶潜在抑制剂的研究。
Adv Sci (Weinh). 2024 Jun;11(21):e2400642. doi: 10.1002/advs.202400642. Epub 2024 Apr 22.
2
Intrinsically Disordered Osteopontin Fragment Orders During Interfacial Calcium Oxalate Mineralization.内在无序骨桥蛋白片段在界面草酸钙矿化过程中有序排列。
Angew Chem Int Ed Engl. 2021 Aug 16;60(34):18577-18581. doi: 10.1002/anie.202105768. Epub 2021 Jul 16.
3
Modulation of Rat Kidney Stone Crystallization and the Relative Oxidative Stress Pathway by Green Tea Polyphenol.
绿茶多酚对大鼠肾结石结晶及相关氧化应激途径的调节作用
ACS Omega. 2021 Jan 7;6(2):1725-1731. doi: 10.1021/acsomega.0c05903. eCollection 2021 Jan 19.
4
Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies.用于治疗草酸盐肾病的草酸钙结晶抑制剂
Adv Sci (Weinh). 2020 Feb 27;7(8):1903337. doi: 10.1002/advs.201903337. eCollection 2020 Apr.
5
In situ flow cell platform for examining calcium oxalate and calcium phosphate crystallization on films of basement membrane extract in the presence of urinary 'inhibitors'.用于在存在尿液“抑制剂”的情况下检测草酸钙和磷酸钙在基底膜提取物膜上结晶的原位流动池平台。
CrystEngComm. 2020 Feb 28;22(8):1448-1458. doi: 10.1039/c9ce01587f. Epub 2020 Feb 5.
6
The role of macromolecules in the formation of kidney stones.大分子在肾结石形成中的作用。
Urolithiasis. 2017 Feb;45(1):57-74. doi: 10.1007/s00240-016-0948-8. Epub 2016 Dec 2.
7
Biopolymer colloids for controlling and templating inorganic synthesis.用于控制和模板化无机合成的生物聚合物胶体。
Beilstein J Nanotechnol. 2014 Nov 17;5:2129-38. doi: 10.3762/bjnano.5.222. eCollection 2014.
8
How the overlapping timescales for peptide binding and terrace exposure lead to non-linear step dynamics during growth of calcium oxalate monohydrate.草酸钙一水合物生长过程中,肽结合和平台暴露的重叠时间尺度如何导致非线性台阶动力学。
Cryst Growth Des. 2010;10(7):2954-2959. doi: 10.1021/cg901626a.
9
Dynamics of Biomineralization and Biodemineralization.生物矿化与生物脱矿的动力学
Met Ions Life Sci. 2010 Jun 1;4:413-456. doi: 10.1002/9780470986325.ch13.
10
Face-specific incorporation of osteopontin into urinary and inorganic calcium oxalate monohydrate and dihydrate crystals.骨桥蛋白在尿液及一水草酸钙和二水草酸钙晶体中特异性地结合于晶体表面。
Urol Res. 2010 Oct;38(5):357-76. doi: 10.1007/s00240-010-0300-7. Epub 2010 Jul 22.